Patents by Inventor David BUEHLMANN

David BUEHLMANN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250362308
    Abstract: The present invention relates to a method for assessing myocardial infarction comprising the steps of determining the amount of a first biomarker in a sample of a subject, said first biomarker being a cardiac Troponin, determining the amount of a second biomarker in a sample of the subject, wherein said second biomarker is selected from the group consisting of: a BMP10-type peptide (Bone Morphogenic Protein 10-type peptide), FGF23 (Fibroblast growth factor 23), a BNP-type peptide, cardiac myosin binding protein C (cMyBPC) and ANG2 (Angiopoietin 2), comparing the amounts of the biomarkers to references for said biomarkers and/or calculating a score for assessing myocardial infarction based on the amounts of the biomarkers, and assessing said subject based on the comparison and/or the calculation.
    Type: Application
    Filed: March 17, 2023
    Publication date: November 27, 2025
    Inventors: David Buehlmann, Magdalena Eberl, Peter Kastner, Alexander Piehler, Ursula-Henrike Wienhues-Thelen, Andre Ziegler
  • Publication number: 20250232875
    Abstract: The present invention relates to a method for assessing myocardial infarction comprising the steps of determining the amount of a first biomarker in a sample of a subject, said first biomarker being cMyBPC, determining the amount of a second biomarker in a sample of the subject, wherein said second biomarker is selected from the group consisting of: a BMP10-type peptide (Bone Morphogenic Protein 10-type peptide), FGF23 (Fibroblast growth factor 23), a BNP-type peptide (Brain natriuretic peptide type peptide), GDF-15 (Growth differentiation factor 15), ANG2 (Angiopoietin 2), CRP (C-reactive protein), ESM1 (endothelial cell specific molecule 1), or a lipid biomarker, such as Cholesterol, LDL (Low Density Lipoprotein) or APOAT (Apolipoprotein A-1) comparing the amounts of the biomarkers to references for said biomarkers and/or calculating a score for assessing myocardial infarction based on the amounts of the biomarkers, and assessing said subject based on the comparison and/or the calculation.
    Type: Application
    Filed: March 17, 2023
    Publication date: July 17, 2025
    Inventors: David Buehlmann, Hartmut Duefel, Magdalena Eberl, Michael Gerg, Peter Kastner, Ulrike Kurtkaya, Alexander Piehler, Ursula-Henrike Wienhues-Thelen, Andre Ziegler
  • Publication number: 20190103779
    Abstract: Some embodiments are directed to a coil for a stator of an electrical slotless motor), the electrical slotless motor including a rotor including at least one magnet (10), the coil including a cylindrical portion (80c) arranged to face the at least one marget, wherein a radial thickness of the cylindrical portion is greater than 28%, preferably 30% of an internal radius of the cylindrical portion.
    Type: Application
    Filed: October 3, 2018
    Publication date: April 4, 2019
    Inventors: Alexis MONTAGNAT-RENTIER, Julien BAUDEY, David BUEHLMANN